Therapeutic Human ExperimentationAntineoplastic AgentsClinical Trials, Phase III as TopicResearch DesignRandomized Controlled Trials as TopicDrug Screening Assays, AntitumorRandom AllocationAnimal Nutritional Physiological PhenomenaCell Line, TumorRadiation, IonizingRadiation DosageClinical Trials as TopicDrug EvaluationData Interpretation, StatisticalNeoplasmsAnimal FeedTreatment OutcomeRadiation InjuriesTime FactorsDoxorubicinFeeding BehaviorApoptosisDrug Resistance, NeoplasmDose-Response Relationship, RadiationRadiation ToleranceAntineoplastic Agents, PhytogenicSwineRadiationCell SurvivalAntibiotics, AntineoplasticAnalysis of VarianceCisplatinDrug Delivery SystemsDisease Models, AnimalRadiation ProtectionRadiation MonitoringDrug CarriersDietTumor Cells, CulturedXenograft Model Antitumor AssaysEllipticinesMice, NudeCell ProliferationCamptothecinEtoposideDNA DamageDrug Resistance, MultiplePaclitaxelInhibitory Concentration 50P-GlycoproteinMolecular StructureDrug DesignDose-Response Relationship, DrugDrug SynergismRadiation OncologyCell CycleDNA Topoisomerases, Type IIGamma RaysProdrugsRadiation-Sensitizing AgentsBreast NeoplasmsTopoisomerase I InhibitorsDaunorubicinEnzyme InhibitorsNanomedicineNanoparticlesCosmic RadiationDrug Evaluation, PreclinicalRadiation Injuries, ExperimentalPlatinumGene Expression Regulation, NeoplasticPlant ExtractsDrug DiscoveryFluorouracilNanocapsulesColonic NeoplasmsRadiation PneumonitisCaspasesAntimetabolites, AntineoplasticOrganoplatinum CompoundsTumor Suppressor Protein p53MitomycinMitoxantroneNeoplasms, Radiation-InducedMolecular Targeted TherapyUltraviolet RaysCaspase 3RadiotherapyCombined Modality TherapyDrugs, InvestigationalProto-Oncogene Proteins c-bcl-2Neoplasms, ExperimentalDNANeoplasm TransplantationDNA RepairMultidrug Resistance-Associated ProteinsIntercalating AgentsBackground RadiationSignal TransductionDNA Adducts